Page last updated: 2024-09-05

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and silver

6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione has been researched along with silver in 1 studies

Compound Research Comparison

Studies
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)
Trials
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)
Recent Studies (post-2010)
(6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione)
Studies
(silver)
Trials
(silver)
Recent Studies (post-2010) (silver)
4902829,47730318,251

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Deng, B; Luo, Z; Mo, G; Mo, K; Qin, D; Wu, Y1

Other Studies

1 other study(ies) available for 6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and silver

ArticleYear
Dual-potential electrochemiluminescence cytosensor based on a metal-organic framework and ABEI-PEI-Au@AgNPs for the simultaneous determination of phosphatidylserine and epidermal growth factor receptors on an apoptotic cell surface.
    Mikrochimica acta, 2023, 08-11, Volume: 190, Issue:9

    Topics: Apoptosis; Biosensing Techniques; Cell Membrane; EGF Family of Proteins; ErbB Receptors; Luminescent Measurements; Metal Nanoparticles; Metal-Organic Frameworks; Phosphatidylserines; Reproducibility of Results; Silver

2023